Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1A | P07327 | 2/20 | 0.61 |
| ▸ | KIT | P10721 | 2/20 | 0.61 |
| ▸ | FLT1 | P17948 | 2/20 | 0.61 |
| ▸ | KDR | P35968 | 2/20 | 0.61 |
| ▸ | ABL2 | P42684 | 2/20 | 0.61 |
| ▸ | FLT4 | P35916 | 1/20 | 0.61 |
| ▸ | AKR1C3 | P42330 | 9/20 | 0.45 |
| ▸ | HRH4 | Q9H3N8 | 6/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | FLT3 | P36888 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6517278 | 1.00 | ADH1A (0.61) | ADH1AKITFLT1KDRABL2 | |
| SCHEMBL6521213 | 0.92 | ADH1A (0.59) | ADH1AKITFLT1KDRABL2 | |
| SCHEMBL6515510 | 0.91 | KIT (0.58) | ADH1AKITFLT1KDRABL2 | |
| SCHEMBL6515515 | 0.91 | KIT (0.58) | ADH1AKITFLT1KDRABL2 | |
| Seco-Cbi-Indole SCHEMBL12596993 | 0.90 | ADH1A (0.51) | ADH1AKITFLT1KDRABL2 | |
| Seco-Cbi-Indole SCHEMBL29468891 | 0.90 | ADH1A (0.51) | ADH1AKITFLT1KDRABL2 | |
| SCHEMBL6525144 | 0.90 | ADH1A (0.57) | ADH1AKITFLT1KDRABL2 | |
| SCHEMBL6525141 | 0.90 | ADH1A (0.57) | ADH1AKITFLT1KDRABL2 | |
| SCHEMBL6522948 | 0.89 | ADH1A (0.56) | ADH1AKITFLT1KDRABL2 | |
| SCHEMBL6525118 | 0.89 | ADH1A (0.56) | ADH1AKITFLT1KDRABL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050026987-A1 | CBI analogues of the duocarmycins and CC-1065 | THE SCRIPPS RESEARCH INSTITUTE (US) | 2005-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050026987-A1 | CBI analogues of the duocarmycins and CC-1065 | CCNI, SP1, DCK | ADH1A 4729/4885KIT 1086/4885FLT1 4650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.